荃银高科(300087) - 2025 Q3 - 季度财报

Financial Performance - Q3 2025 revenue was CNY 497,754,348.82, a decrease of 22.78% year-over-year[4] - Net profit attributable to shareholders was a loss of CNY 138,682,490.13, down 123.34% compared to the same period last year[4] - The company achieved operating revenue of CNY 1,933.88 million, a decrease of 5.90% compared to the same period last year[14] - The net profit attributable to shareholders was CNY -180.12 million, a decline of 113.45% year-on-year, primarily due to high product homogeneity and intensified market competition[14] - Net loss for the period was CNY 254,891,246.58, compared to a net loss of CNY 119,268,802.60 in the previous period, indicating a significant increase in losses[21] - Basic and diluted earnings per share were both reported at -0.1900, compared to -0.0890 in the previous period, indicating a worsening of earnings per share[21] Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date was CNY -198,861,807.39, an improvement of 20.53% from the previous year[4] - The net cash flow from operating activities was -198,861,807.39, compared to -250,250,503.64 in the previous period, indicating an improvement of approximately 20.5%[23] - Total cash inflow from investment activities was 291,524,634.65, while cash outflow was 312,849,843.01, resulting in a net cash flow of -21,325,208.36, an improvement from -224,487,961.08 in the previous period[23] - Cash inflow from financing activities totaled 1,580,081,153.00, while cash outflow was 1,639,049,006.32, leading to a net cash flow of -58,967,853.32, a decline from 602,729,125.14 in the previous period[23] - The total cash and cash equivalents at the end of the period was 1,292,185,780.71, down from 1,610,507,686.54 in the previous period, reflecting a decrease of approximately 19.7%[23] Assets and Liabilities - Total assets at the end of Q3 2025 were CNY 7,537,006,748.55, a decrease of 1.51% from the end of the previous year[4] - The company's equity attributable to shareholders decreased by 11.51% to CNY 1,742,228,259.35 compared to the end of the previous year[4] - Total non-current assets increased to CNY 2,020,072,396.79 from CNY 1,738,583,685.62, reflecting a growth of approximately 16.2%[19] - Total liabilities increased to CNY 5,225,398,742.37 from CNY 5,030,356,423.14, representing an increase of about 3.9% year-over-year[19] - The company's total assets decreased slightly to CNY 7,537,006,748.55 from CNY 7,652,407,216.86, a decline of approximately 1.5%[19] Income and Expenses - Other income increased by 86.31% to CNY 44,653,481.62 year-to-date, primarily due to increased government subsidies[9] - Investment income surged by 1961.57% to CNY 14,677,541.09, attributed to interest income from the transfer of large certificates of deposit[9] - Research and development expenses rose to CNY 74,410,679.70 from CNY 61,511,504.86, marking an increase of approximately 21% year-over-year[20] - Total operating costs increased to CNY 2,224,819,260.49 from CNY 2,172,377,628.50, reflecting an increase of about 2.4% year-over-year[20] Shareholder Information - The total number of common shareholders at the end of the reporting period was 44,749, with the largest shareholder, China Seed Group Co., Ltd., holding 20.51% of shares[10] - The company plans to distribute a cash dividend of CNY 0.5 per 10 shares, totaling CNY 47.37 million, based on the total issued share capital of 947,331,751 shares as of December 31, 2024[14] - The company’s total number of preferred shareholders was zero, indicating no preferred shares outstanding[12] Inventory and Receivables - The inventory balance increased to CNY 3,044.98 million from CNY 2,988.86 million at the beginning of the period[17] - The company’s long-term receivables rose to CNY 173.24 million from CNY 167.63 million at the beginning of the period[17] - The company’s total current assets decreased from CNY 5,913.82 million to CNY 5,516.93 million[17]